¥4,440.00
0.25% today
Tokyo, Nov 21, 06:45 am CET
ISIN
JP3463000004
Symbol
4502
Index

Takeda Pharmaceutical Stock price

¥4,451.00
+229.00 5.42% 1M
+365.00 8.93% 6M
+270.00 6.46% YTD
+269.00 6.43% 1Y
+493.00 12.46% 3Y
+802.00 21.98% 5Y
-1,741.00 28.12% 10Y
-2,189.00 32.97% 20Y
Tokyo, Closing price Thu, Nov 20 2025
+41.00 0.93%
ISIN
JP3463000004
Symbol
4502
Index
Industry

New AI Insights on Takeda Pharmaceutical Insights AI Insights on Takeda Pharmaceutical

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
¥7.0t
Enterprise Value
¥10.9t
Net debt
¥3.9t
Cash
¥739.7b
Shares outstanding
1.6b
Valuation (TTM | estimate)
P/E
212.4 | 30.7
P/S
1.6 | 1.5
EV/Sales
2.5 | 2.4
EV/FCF
11.8
P/B
1.0
Dividends
DPS
¥200.00
Yield 1Y | 5Y
4.5% | 4.7%
Growth 1Y | 5Y
2.0% | 2.1%
Payout 1Y | 3Y
286.7% | 155.6%
Increased
3 Years
Financials (TTM | estimate)
Revenue
¥4.4t | ¥4.6t
EBITDA
¥920.4b | ¥1.2t
EBIT
¥373.6b | ¥402.0b
Net Income
¥33.1b | ¥229.3b
Free Cash Flow
¥922.3b
Growth (TTM | estimate)
Revenue
-2.8% | 0.0%
EBITDA
-15.3% | 13.1%
EBIT
-31.1% | -25.2%
Net Income
-88.6% | 112.5%
Free Cash Flow
72.0%
Margin (TTM | estimate)
Gross
64.6%
EBITDA
20.8% | 27.2%
EBIT
8.5%
Net
0.8% | 5.0%
Free Cash Flow
20.9%
Financial Health
Equity Ratio
48.7%
Return on Equity
1.6%
ROCE
3.0%
ROIC
1.1%
Debt/Equity
0.7
More
EPS
¥21.0
FCF per Share
¥583.9
Short interest
-
Employees
49k
Rev per Employee
¥93.0m
Show more

Is Takeda Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Takeda Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Takeda Pharmaceutical forecast:

10x Buy
53%
9x Hold
47%

Analyst Opinions

19 Analysts have issued a Takeda Pharmaceutical forecast:

Buy
53%
Hold
47%

Financial data from Takeda Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
4,417,004 4,417,004
3% 3%
100%
- Direct Costs 1,563,688 1,563,688
1% 1%
35%
2,853,316 2,853,316
5% 5%
65%
- Selling and Administrative Expenses 1,075,890 1,075,890
1% 1%
24%
- Research and Development Expense 691,573 691,573
5% 5%
16%
920,352 920,352
15% 15%
21%
- Depreciation and Amortization 546,775 546,775
0% 0%
12%
EBIT (Operating Income) EBIT 373,577 373,577
31% 31%
8%
Net Profit 33,075 33,075
89% 89%
1%

In millions JPY.

Don't miss a Thing! We will send you all news about Takeda Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Takeda Pharmaceutical Stock News

AD HOC NEWS
22 days ago
Takeda Pharmaceutical Company Limited / JP3463000004

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Head office Japan
CEO Christophe Weber
Employees 49,281
Founded 1781
Website www.takeda.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today